[
    {
        "molecule_name": "peptide",
        "protein_target_name": "meditope binding site",
        "binding_metric": "Kd",
        "value": "<10",
        "unit": "μM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn some asepcts, the meditope (e.g., the peptide) binds to the meditope binding site with a dissociation constant of of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nM, or less, such as at or about 200 picomolar or less, for example, with such a dissociation constant, as measured by a particular technique, such as surface plasmon resonance (SPR), Isothermal Titration Calorimetry (ITC), fluorescence, fluorescence polarization, NMR, IR, calorimetry titrations; Kinetic exclusion; Circular dichroism, differential scanning calorimetry, or other known method, e.g., by SPR."
    },
    {
        "molecule_name": "peptide",
        "protein_target_name": "meditope binding site",
        "binding_metric": "Kd",
        "value": "<5",
        "unit": "μM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn some asepcts, the meditope (e.g., the peptide) binds to the meditope binding site with a dissociation constant of of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nM, or less, such as at or about 200 picomolar or less, for example, with such a dissociation constant, as measured by a particular technique, such as surface plasmon resonance (SPR), Isothermal Titration Calorimetry (ITC), fluorescence, fluorescence polarization, NMR, IR, calorimetry titrations; Kinetic exclusion; Circular dichroism, differential scanning calorimetry, or other known method, e.g., by SPR."
    },
    {
        "molecule_name": "peptide",
        "protein_target_name": "meditope binding site",
        "binding_metric": "Kd",
        "value": "<2",
        "unit": "μM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn some asepcts, the meditope (e.g., the peptide) binds to the meditope binding site with a dissociation constant of of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nM, or less, such as at or about 200 picomolar or less, for example, with such a dissociation constant, as measured by a particular technique, such as surface plasmon resonance (SPR), Isothermal Titration Calorimetry (ITC), fluorescence, fluorescence polarization, NMR, IR, calorimetry titrations; Kinetic exclusion; Circular dichroism, differential scanning calorimetry, or other known method, e.g., by SPR."
    },
    {
        "molecule_name": "peptide",
        "protein_target_name": "meditope binding site",
        "binding_metric": "Kd",
        "value": "<1",
        "unit": "μM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn some asepcts, the meditope (e.g., the peptide) binds to the meditope binding site with a dissociation constant of of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nM, or less, such as at or about 200 picomolar or less, for example, with such a dissociation constant, as measured by a particular technique, such as surface plasmon resonance (SPR), Isothermal Titration Calorimetry (ITC), fluorescence, fluorescence polarization, NMR, IR, calorimetry titrations; Kinetic exclusion; Circular dichroism, differential scanning calorimetry, or other known method, e.g., by SPR."
    },
    {
        "molecule_name": "peptide",
        "protein_target_name": "meditope binding site",
        "binding_metric": "Kd",
        "value": "<500",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn some asepcts, the meditope (e.g., the peptide) binds to the meditope binding site with a dissociation constant of of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nM, or less, such as at or about 200 picomolar or less, for example, with such a dissociation constant, as measured by a particular technique, such as surface plasmon resonance (SPR), Isothermal Titration Calorimetry (ITC), fluorescence, fluorescence polarization, NMR, IR, calorimetry titrations; Kinetic exclusion; Circular dichroism, differential scanning calorimetry, or other known method, e.g., by SPR."
    },
    {
        "molecule_name": "peptide",
        "protein_target_name": "meditope binding site",
        "binding_metric": "Kd",
        "value": "<400",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn some asepcts, the meditope (e.g., the peptide) binds to the meditope binding site with a dissociation constant of of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nM, or less, such as at or about 200 picomolar or less, for example, with such a dissociation constant, as measured by a particular technique, such as surface plasmon resonance (SPR), Isothermal Titration Calorimetry (ITC), fluorescence, fluorescence polarization, NMR, IR, calorimetry titrations; Kinetic exclusion; Circular dichroism, differential scanning calorimetry, or other known method, e.g., by SPR."
    },
    {
        "molecule_name": "peptide",
        "protein_target_name": "meditope binding site",
        "binding_metric": "Kd",
        "value": "<300",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn some asepcts, the meditope (e.g., the peptide) binds to the meditope binding site with a dissociation constant of of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nM, or less, such as at or about 200 picomolar or less, for example, with such a dissociation constant, as measured by a particular technique, such as surface plasmon resonance (SPR), Isothermal Titration Calorimetry (ITC), fluorescence, fluorescence polarization, NMR, IR, calorimetry titrations; Kinetic exclusion; Circular dichroism, differential scanning calorimetry, or other known method, e.g., by SPR."
    },
    {
        "molecule_name": "peptide",
        "protein_target_name": "meditope binding site",
        "binding_metric": "Kd",
        "value": "<200",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn some asepcts, the meditope (e.g., the peptide) binds to the meditope binding site with a dissociation constant of of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nM, or less, such as at or about 200 picomolar or less, for example, with such a dissociation constant, as measured by a particular technique, such as surface plasmon resonance (SPR), Isothermal Titration Calorimetry (ITC), fluorescence, fluorescence polarization, NMR, IR, calorimetry titrations; Kinetic exclusion; Circular dichroism, differential scanning calorimetry, or other known method, e.g., by SPR."
    },
    {
        "molecule_name": "peptide",
        "protein_target_name": "meditope binding site",
        "binding_metric": "Kd",
        "value": "<100",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn some asepcts, the meditope (e.g., the peptide) binds to the meditope binding site with a dissociation constant of of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nM, or less, such as at or about 200 picomolar or less, for example, with such a dissociation constant, as measured by a particular technique, such as surface plasmon resonance (SPR), Isothermal Titration Calorimetry (ITC), fluorescence, fluorescence polarization, NMR, IR, calorimetry titrations; Kinetic exclusion; Circular dichroism, differential scanning calorimetry, or other known method, e.g., by SPR."
    },
    {
        "molecule_name": "peptide",
        "protein_target_name": "meditope binding site",
        "binding_metric": "Kd",
        "value": "<200",
        "unit": "picomolar",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nIn some asepcts, the meditope (e.g., the peptide) binds to the meditope binding site with a dissociation constant of of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nM, or less, such as at or about 200 picomolar or less, for example, with such a dissociation constant, as measured by a particular technique, such as surface plasmon resonance (SPR), Isothermal Titration Calorimetry (ITC), fluorescence, fluorescence polarization, NMR, IR, calorimetry titrations; Kinetic exclusion; Circular dichroism, differential scanning calorimetry, or other known method, e.g., by SPR."
    },
    {
        "molecule_name": "peptide",
        "protein_target_name": "meditope",
        "binding_metric": "Kd",
        "value": "<10",
        "unit": "μΜ",
        "raw_mentions": "In some cases, the peptide binds to the meditope binding site with a dissociation constant of less than 10 μΜ, as measured by surface plasmon resonance (SPR), or another affinity as described above."
    },
    {
        "molecule_name": "antibodies",
        "protein_target_name": "meditope(s)",
        "binding_metric": "dissociation constant",
        "value": "<10",
        "unit": "μΜ",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* For example, in certain aspects, the antibodies bind to the meditope(s) with a dissociation constant of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nM, or less, such as at or about 200 picomolar or less.\n* For example, in some cases, the analog or meditope exhibits a binding constant of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nm, or less, as measured by SPR or as measured by ITC or as measured by any of these methods.\n* In a study reported herein, x-ray crystallographic analysis has revealed that the peptides of SEQ ID NO: 1 binds to a meditope-binding site within the central cavity of the cetuximab Fab fragment, defined by various residues of the heavy and light chains (see Figures 1 and 4A), with a binding constant of -700 nM (see Figures 30A- 30B)."
    },
    {
        "molecule_name": "antibodies",
        "protein_target_name": "meditope(s)",
        "binding_metric": "dissociation constant",
        "value": "<5",
        "unit": "μΜ",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* For example, in certain aspects, the antibodies bind to the meditope(s) with a dissociation constant of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nM, or less, such as at or about 200 picomolar or less.\n* For example, in some cases, the analog or meditope exhibits a binding constant of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nm, or less, as measured by SPR or as measured by ITC or as measured by any of these methods.\n* In a study reported herein, x-ray crystallographic analysis has revealed that the peptides of SEQ ID NO: 1 binds to a meditope-binding site within the central cavity of the cetuximab Fab fragment, defined by various residues of the heavy and light chains (see Figures 1 and 4A), with a binding constant of -700 nM (see Figures 30A- 30B)."
    },
    {
        "molecule_name": "antibodies",
        "protein_target_name": "meditope(s)",
        "binding_metric": "dissociation constant",
        "value": "<2",
        "unit": "μΜ",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* For example, in certain aspects, the antibodies bind to the meditope(s) with a dissociation constant of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nM, or less, such as at or about 200 picomolar or less.\n* For example, in some cases, the analog or meditope exhibits a binding constant of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nm, or less, as measured by SPR or as measured by ITC or as measured by any of these methods.\n* In a study reported herein, x-ray crystallographic analysis has revealed that the peptides of SEQ ID NO: 1 binds to a meditope-binding site within the central cavity of the cetuximab Fab fragment, defined by various residues of the heavy and light chains (see Figures 1 and 4A), with a binding constant of -700 nM (see Figures 30A- 30B)."
    },
    {
        "molecule_name": "antibodies",
        "protein_target_name": "meditope(s)",
        "binding_metric": "dissociation constant",
        "value": "<1",
        "unit": "μΜ",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* For example, in certain aspects, the antibodies bind to the meditope(s) with a dissociation constant of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nM, or less, such as at or about 200 picomolar or less.\n* For example, in some cases, the analog or meditope exhibits a binding constant of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nm, or less, as measured by SPR or as measured by ITC or as measured by any of these methods.\n* In a study reported herein, x-ray crystallographic analysis has revealed that the peptides of SEQ ID NO: 1 binds to a meditope-binding site within the central cavity of the cetuximab Fab fragment, defined by various residues of the heavy and light chains (see Figures 1 and 4A), with a binding constant of -700 nM (see Figures 30A- 30B)."
    },
    {
        "molecule_name": "antibodies",
        "protein_target_name": "meditope(s)",
        "binding_metric": "dissociation constant",
        "value": "<500",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* For example, in certain aspects, the antibodies bind to the meditope(s) with a dissociation constant of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nM, or less, such as at or about 200 picomolar or less.\n* For example, in some cases, the analog or meditope exhibits a binding constant of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nm, or less, as measured by SPR or as measured by ITC or as measured by any of these methods.\n* In a study reported herein, x-ray crystallographic analysis has revealed that the peptides of SEQ ID NO: 1 binds to a meditope-binding site within the central cavity of the cetuximab Fab fragment, defined by various residues of the heavy and light chains (see Figures 1 and 4A), with a binding constant of -700 nM (see Figures 30A- 30B)."
    },
    {
        "molecule_name": "antibodies",
        "protein_target_name": "meditope(s)",
        "binding_metric": "dissociation constant",
        "value": "<400",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* For example, in certain aspects, the antibodies bind to the meditope(s) with a dissociation constant of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nM, or less, such as at or about 200 picomolar or less.\n* For example, in some cases, the analog or meditope exhibits a binding constant of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nm, or less, as measured by SPR or as measured by ITC or as measured by any of these methods.\n* In a study reported herein, x-ray crystallographic analysis has revealed that the peptides of SEQ ID NO: 1 binds to a meditope-binding site within the central cavity of the cetuximab Fab fragment, defined by various residues of the heavy and light chains (see Figures 1 and 4A), with a binding constant of -700 nM (see Figures 30A- 30B)."
    },
    {
        "molecule_name": "antibodies",
        "protein_target_name": "meditope(s)",
        "binding_metric": "dissociation constant",
        "value": "<300",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* For example, in certain aspects, the antibodies bind to the meditope(s) with a dissociation constant of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nM, or less, such as at or about 200 picomolar or less.\n* For example, in some cases, the analog or meditope exhibits a binding constant of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nm, or less, as measured by SPR or as measured by ITC or as measured by any of these methods.\n* In a study reported herein, x-ray crystallographic analysis has revealed that the peptides of SEQ ID NO: 1 binds to a meditope-binding site within the central cavity of the cetuximab Fab fragment, defined by various residues of the heavy and light chains (see Figures 1 and 4A), with a binding constant of -700 nM (see Figures 30A- 30B)."
    },
    {
        "molecule_name": "antibodies",
        "protein_target_name": "meditope(s)",
        "binding_metric": "dissociation constant",
        "value": "<200",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* For example, in certain aspects, the antibodies bind to the meditope(s) with a dissociation constant of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nM, or less, such as at or about 200 picomolar or less.\n* For example, in some cases, the analog or meditope exhibits a binding constant of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nm, or less, as measured by SPR or as measured by ITC or as measured by any of these methods.\n* In a study reported herein, x-ray crystallographic analysis has revealed that the peptides of SEQ ID NO: 1 binds to a meditope-binding site within the central cavity of the cetuximab Fab fragment, defined by various residues of the heavy and light chains (see Figures 1 and 4A), with a binding constant of -700 nM (see Figures 30A- 30B)."
    },
    {
        "molecule_name": "antibodies",
        "protein_target_name": "meditope(s)",
        "binding_metric": "dissociation constant",
        "value": "<100",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* For example, in certain aspects, the antibodies bind to the meditope(s) with a dissociation constant of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nM, or less, such as at or about 200 picomolar or less.\n* For example, in some cases, the analog or meditope exhibits a binding constant of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nm, or less, as measured by SPR or as measured by ITC or as measured by any of these methods.\n* In a study reported herein, x-ray crystallographic analysis has revealed that the peptides of SEQ ID NO: 1 binds to a meditope-binding site within the central cavity of the cetuximab Fab fragment, defined by various residues of the heavy and light chains (see Figures 1 and 4A), with a binding constant of -700 nM (see Figures 30A- 30B)."
    },
    {
        "molecule_name": "antibodies",
        "protein_target_name": "meditope(s)",
        "binding_metric": "dissociation constant",
        "value": "200",
        "unit": "picomolar",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* For example, in certain aspects, the antibodies bind to the meditope(s) with a dissociation constant of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nM, or less, such as at or about 200 picomolar or less.\n* For example, in some cases, the analog or meditope exhibits a binding constant of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nm, or less, as measured by SPR or as measured by ITC or as measured by any of these methods.\n* In a study reported herein, x-ray crystallographic analysis has revealed that the peptides of SEQ ID NO: 1 binds to a meditope-binding site within the central cavity of the cetuximab Fab fragment, defined by various residues of the heavy and light chains (see Figures 1 and 4A), with a binding constant of -700 nM (see Figures 30A- 30B)."
    },
    {
        "molecule_name": "peptides of SEQ ID NO: 1",
        "protein_target_name": "cetuximab Fab fragment",
        "binding_metric": "binding constant",
        "value": "-700",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* For example, in certain aspects, the antibodies bind to the meditope(s) with a dissociation constant of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nM, or less, such as at or about 200 picomolar or less.\n* For example, in some cases, the analog or meditope exhibits a binding constant of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nm, or less, as measured by SPR or as measured by ITC or as measured by any of these methods.\n* In a study reported herein, x-ray crystallographic analysis has revealed that the peptides of SEQ ID NO: 1 binds to a meditope-binding site within the central cavity of the cetuximab Fab fragment, defined by various residues of the heavy and light chains (see Figures 1 and 4A), with a binding constant of -700 nM (see Figures 30A- 30B)."
    },
    {
        "molecule_name": "putative meditopes of small molecules",
        "protein_target_name": "meditope-enabled antibody",
        "binding_metric": "binding dissociation constant",
        "value": "<0.70",
        "unit": "μΜ",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* In other contexts, a low affinity meditope is desired, such that a minimum dissociation constant is specified, for example, 0.70 μΜ.\n* In some examples, the candidate is identified as a meditope or analog thereof if it exhibits binding constant of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nm, or less.\n* For example, in some cases, the analog or meditope exhibits a binding constant of less than at or about 10 μΜ, less than at or about 5 μΜ, or less than at or about 2 μΜ, less than at or about 1 μΜ, less than at or about 500, 400, 300, 200, 100 nm, or less, as measured by SPR or as measured by ITC or as measured by any of these methods.\n* determining whether the putative meditopes of small molecules bind the meditope-enabled antibody at a framework binding interface; identifying one or more candidate meditopes or meditope analogs; determining binding affinity of the one or more candidates; and identifying one or more of the candidates as a meditope or meditope analogs when the binding dissociation constant is less than 0.70 μΜ."
    },
    {
        "molecule_name": "cetuximab",
        "protein_target_name": "sEGFRdlll",
        "binding_metric": "binding constant",
        "value": "20",
        "unit": "nM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\nTitration of labeled cetuximab with labeled sEGFRdlll afforded a binding constant of 20 nM, essentially the same value as was observed using SPR (data not shown).\nThe experiment was performed in triplicate with labeled cetuximab Fab incubated with sEGFRdlll at concentrations ranging from 5 to 1000 nM in the presence of the cQFD meditope (66 μΜ).\nHowever, relative to Fab binding, the cQFD meditope did not saturate the scFv at concentrations as high as 100 μΜ of meditope."
    },
    {
        "molecule_name": "meditope-enabled trastuzumab",
        "protein_target_name": "Protein L",
        "binding_metric": "binding constant",
        "value": "0.5",
        "unit": "μM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n1. The binding constant for the interaction between Protein L and the meditope-enabled trastuzumab was approximately 0.5 μΜ.\n2. For the interaction between the meditope and the meditope-enabled trastuzumab Fab fragment, it was approximately 1 μΜ.\n3. The binding constant for the interaction between the meditope- Protein L fusion protein and the IgG, however, was 165 pM.\n4. The fit data indicates a binding affinity of 165 pM.\n5. The binding constant was reduced, but no specific value is given for the point mutations in Protein L and the meditope. (This sentence does not meet the criteria, I apologize for the mistake)\n \n\nOnly the first four sentences meet the criteria, as they contain a specific molecule name, a bioactivity metric, a numeric value, and a unit."
    },
    {
        "molecule_name": "meditope-enabled trastuzumab Fab fragment",
        "protein_target_name": "meditope",
        "binding_metric": "binding constant",
        "value": "1",
        "unit": "μM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n1. The binding constant for the interaction between Protein L and the meditope-enabled trastuzumab was approximately 0.5 μΜ.\n2. For the interaction between the meditope and the meditope-enabled trastuzumab Fab fragment, it was approximately 1 μΜ.\n3. The binding constant for the interaction between the meditope- Protein L fusion protein and the IgG, however, was 165 pM.\n4. The fit data indicates a binding affinity of 165 pM.\n5. The binding constant was reduced, but no specific value is given for the point mutations in Protein L and the meditope. (This sentence does not meet the criteria, I apologize for the mistake)\n \n\nOnly the first four sentences meet the criteria, as they contain a specific molecule name, a bioactivity metric, a numeric value, and a unit."
    },
    {
        "molecule_name": "IgG",
        "protein_target_name": "meditope-Protein L fusion protein",
        "binding_metric": "binding constant",
        "value": "165",
        "unit": "pM",
        "raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n1. The binding constant for the interaction between Protein L and the meditope-enabled trastuzumab was approximately 0.5 μΜ.\n2. For the interaction between the meditope and the meditope-enabled trastuzumab Fab fragment, it was approximately 1 μΜ.\n3. The binding constant for the interaction between the meditope- Protein L fusion protein and the IgG, however, was 165 pM.\n4. The fit data indicates a binding affinity of 165 pM.\n5. The binding constant was reduced, but no specific value is given for the point mutations in Protein L and the meditope. (This sentence does not meet the criteria, I apologize for the mistake)\n \n\nOnly the first four sentences meet the criteria, as they contain a specific molecule name, a bioactivity metric, a numeric value, and a unit."
    }
]